http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111936858-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-47 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57446 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2020-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111936858-B |
| titleOfInvention | A very early gastric cancer cell marker and early gastric cancer precancerous cell marker and its application in diagnostic kits |
| abstract | The present inventors discovered a group of cells (named "very early gastric cancer cells") that appear at the stage of gastric low-grade dysplasia, have specific molecular characteristics, and have a high risk of carcinogenesis, which can be used as a marker for very early diagnosis of gastric cancer. Molecular markers of very early gastric cancer cells are used to prepare kits for early diagnosis of gastric cancer or other digestive system tumors based on gastric tissue or blood samples. This very early gastric cancer cell marker can also distinguish the risk of postoperative recurrence of gastric cancer and the risk of tumors in digestive system organs such as the intestine, pancreas, and esophagus. In addition, the inventors have also found that a group of cells with specific molecular characteristics that appear in the early stage of gastric precancerous lesions can be used as markers for early diagnosis of gastric precancerous lesions, and are also integrated into the kit. The invention can be used for early clinical diagnosis of gastric cancer and other digestive tract tumors, and can also be used as an intervention target for the prevention and treatment of the above-mentioned digestive tract tumors, and has a good application prospect. |
| priorityDate | 2019-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 75.